Head and Neck Cancer News and Research

RSS

Head and Neck Cancer is cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx [voice box]).

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

...

16 Oct 2013

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

...

15 Oct 2013

Epigenetic Markers Found For Head And Neck Cancers

...

2 Oct 2013

Unique DNA markings on certain genes may 'predict' risk of developing head and neck cancer

Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.

1 Oct 2013

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma cancer patients treated with intensity modulated proton therapy decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy.

26 Sep 2013

Proton therapy reduces treatment side effects among head and neck cancer patients

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.

25 Sep 2013

Researchers blame HPV for increased number of young adults with oropharyngeal cancer

The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit.

25 Sep 2013

Dental caries show ‘unexpected’ relationship with head and neck cancer

People with dental caries have a reduced risk for developing head and neck squamous cell carcinoma, a large case-control study has found.

24 Sep 2013

Swallow therapy combats post-radiotherapy dysphagia

Swallowing exercises can help to minimize the risk for dysphagia in patients undergoing radiotherapy for head and neck cancer, a case study suggests.

20 Sep 2013

ASTRO to award $8,000 Survivor Circle grants to two Georgia cancer patient support groups

The American Society for Radiation Oncology (ASTRO) has selected two Georgia cancer patient support groups, The Cancer Foundation of Northeast Georgia and the South Georgia Medical Center, Pearlman Cancer Center, to receive ASTRO's 2013 Survivor Circle grants.

19 Sep 2013

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.

16 Sep 2013

Molecular marker predicts longer survival among patients prescribed two cancer drugs

Johns Hopkins scientists have identified a molecular marker called "Mig 6" that appears to accurately predict longer survival -- up to two years -- among patients prescribed two of the most widely used drugs in a class of anticancer agents called EGFR inhibitors.

6 Sep 2013

Head and neck cancer patients receiving radiation benefit from swallowing exercises

A study at UCLA's Jonsson Comprehensive Cancer Center has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to need a feeding tube or suffer unwanted side effects such as worsening of diet or narrowing of the throat passage if they performed a set of prescribed swallowing exercises - called a "swallow preservation protocol" - during therapy.

5 Sep 2013

Head, neck cancer patients receiving radiation complied with SPP likely to suffer side effects

A study from UCLA's Jonsson Comprehensive Cancer Center (JCCC) has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to suffer unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises called a swallow preservation protocol (SPP) during therapy.

30 Aug 2013

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

Otolaryngologists to present newest specialty research in OTO EXPO

The 2013 Annual Meeting & OTO EXPOSM of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 29 - October 2, at the Vancouver Convention Centre in Vancouver, BC, Canada.

17 Aug 2013

International meeting to focus on carbon ion radiotherapy for cancer patients

Cancer experts from around the world are converging in Denver on Thursday and Friday to analyze the success of cutting-edge radiation therapies, and to determine how one promising treatment option could be delivered for the first time to cancer patients in the United States.

2 Aug 2013

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its Targeted Antibody Payload (TAP) ADC technology, today announced that the Company's x (IND) application has been accepted by the US FDA and is now active.

2 Aug 2013

UPCI research could provide roadmap for developing personalized therapies for breast cancer

More than 230,000 women will be diagnosed with breast cancer in the U.S. this year, a diagnosis that comes with treatment choices that can be overwhelming to patients and complex to their doctors. But what if there was only one treatment for your breast cancer? And what if it was based on your genetics and specific cancer type in the hope of maximizing its effectiveness?

24 Jul 2013

Cedars-Sinai's first accredited Complex Surgical Oncology Fellowship program established

The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has established the medical center's first accredited Complex Surgical Oncology Fellowship program, joining an elite group of 16 U.S. hospitals that have received accreditation for this type of training from the Accreditation Council for Graduate Medical Education, a premier evaluator of physician education programs.

22 Jul 2013

Head and Neck Cancer News and Research

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

Epigenetic Markers Found For Head And Neck Cancers

Unique DNA markings on certain genes may 'predict' risk of developing head and neck cancer

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

Proton therapy reduces treatment side effects among head and neck cancer patients

Researchers blame HPV for increased number of young adults with oropharyngeal cancer

Dental caries show ‘unexpected’ relationship with head and neck cancer

Swallow therapy combats post-radiotherapy dysphagia

ASTRO to award $8,000 Survivor Circle grants to two Georgia cancer patient support groups

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

Molecular marker predicts longer survival among patients prescribed two cancer drugs

Head and neck cancer patients receiving radiation benefit from swallowing exercises

Head, neck cancer patients receiving radiation complied with SPP likely to suffer side effects

Seven researchers to receive grants from ASTRO to advance radiation oncology research

Otolaryngologists to present newest specialty research in OTO EXPO

International meeting to focus on carbon ion radiotherapy for cancer patients

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

UPCI research could provide roadmap for developing personalized therapies for breast cancer

Cedars-Sinai's first accredited Complex Surgical Oncology Fellowship program established

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News